About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Pre-clinical and Clinical Study Results for the Coracto™ Rapamycin-eluting Stent – A New-generation Drug-eluting Stent

Citation:

Interventional Cardiology 2010;5:39–42

The Role of Revascularisation in Patients Undergoing Non-cardiac Surgery

Citation:

Interventional Cardiology 2010;5:104–8

Percutaneous Treatment of Congenital Defects of the Inter-atrial Septum in Adults - Recent Advances and Persistent Pitfalls

Citation:

Interventional Cardiology 2009;4(1):76-80

Second - versus First-generation Drug-eluting Stents

Citation:

Interventional Cardiology 2010;5:23–6